The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages

The Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has demonstrated promising efficacy in a variety of hematologic malignancies. However, the precise mechanism of action of the drug remains to be fully elucidated. Tumor-infiltrating macrophages presented in the tumor microenvironment have b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Ping, Lingyan, Ding, Ning, Shi, Yunfei, Feng, Lixia, Li, Jiao, Liu, Yalu, Lin, Yufu, Shi, Cunzhen, Wang, Xing, Pan, Zhengying, Song, Yuqin, Zhu, Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503608/
https://ncbi.nlm.nih.gov/pubmed/28424405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16836
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky